Acute Coronary Syndrome during the Pandemic New Coronavirus Infection
The experience of managing patients with COVID-19 around the world has shown that, although respiratory symptoms predominate during the manifestation of infection, then many patients can develop serious damage to the cardiovascular system. However, coronary artery disease (CHD) remains the leadin...
Saved in:
Main Authors: | O. M. Drapkina, A. Ya. Kravchenko, A. V. Budnevskiy, A. V. Kontsevaya, E. S. Ovsyannikov, E. S. Drobysheva |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2023-03-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2886 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnosis and treatment of acute coronary syndrome during the novel coronavirus infection COVID-19 pandemic
by: A. M. Namitokov, et al.
Published: (2020-05-01) -
Acute coronary syndrome: how to reduce the residual inflammatory risk?
by: V. I. Shalnev
Published: (2020-03-01) -
Difficulties in managing a patient with acute coronary syndrome, the clinical case
by: A. A. Bruzgina, et al.
Published: (2023-11-01) -
Statins in acute coronary syndrome
by: O. M. Drapkina
Published: (2009-10-01) -
Comparison of outcomes of coronary artery stenting in acute myocardial infarction due to massive coronary thrombosis
by: A. V. Azarov, et al.
Published: (2023-12-01)